FDA Approved: ERIBULIN MESYLATE — Original Application (Kindos Pharmaceuticals Co., Ltd.)

View source ↗

Summary

FDA approves an original application for Eribulin Mesylate from Kindos Pharmaceuticals Co., Ltd., enabling its generic product to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Liposarcoma

Drugs mentioned

• ERIBULIN MESYLATE (Eribulin mesylate)

Snippet

ORIG AP for ERIBULIN MESYLATE (ERIBULIN MESYLATE)